These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Substitutions in PBP3 confer resistance to both ampicillin and extended-spectrum cephalosporins in Haemophilus parainfluenzae as revealed by site-directed mutagenesis and gene recombinants. Wienholtz NH, Barut A, Nørskov-Lauritsen N. J Antimicrob Chemother; 2017 Sep 01; 72(9):2544-2547. PubMed ID: 28582518 [Abstract] [Full Text] [Related]
3. Contribution of PBP3 Substitutions and TEM-1, TEM-15, and ROB-1 Beta-Lactamases to Cefotaxime Resistance in Haemophilus influenzae and Haemophilus parainfluenzae. Søndergaard A, Nørskov-Lauritsen N. Microb Drug Resist; 2016 Jun 01; 22(4):247-52. PubMed ID: 26683319 [Abstract] [Full Text] [Related]
4. Emergence of extensively drug-resistant Haemophilus parainfluenzae in Switzerland. Tinguely R, Seiffert SN, Furrer H, Perreten V, Droz S, Endimiani A. Antimicrob Agents Chemother; 2013 Jun 01; 57(6):2867-9. PubMed ID: 23545526 [Abstract] [Full Text] [Related]
5. Molecular characterization of a clinical Haemophilus parainfluenzae isolate with cefotaxime resistance and decreased susceptibility to fluoroquinolones. Faccone D, Lopez-Ruitti P, Vazquez M, Guerriero L, Lucero C, Gagetti P, Ceriana P, Corso A. Infect Genet Evol; 2016 Oct 01; 44():507-509. PubMed ID: 27497656 [Abstract] [Full Text] [Related]
7. Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain. Sierra Y, González-Díaz A, Tubau F, Imaz A, Cubero M, Càmara J, Ayats J, Martí S, Ardanuy C. Eur J Clin Microbiol Infect Dis; 2020 Apr 01; 39(4):703-710. PubMed ID: 31828685 [Abstract] [Full Text] [Related]
8. Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project. Soriano F, Granizo JJ, Coronel P, Gimeno M, Ródenas E, Gracia M, García C, Fernández-Roblas R, Esteban J, Gadea I. Int J Antimicrob Agents; 2004 Mar 01; 23(3):296-9. PubMed ID: 15164972 [Abstract] [Full Text] [Related]
9. Assessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp. Sierra Y, Tubau F, González-Díaz A, Carrera-Salinas A, Moleres J, Bajanca-Lavado P, Garmendia J, Domínguez MÁ, Ardanuy C, Martí S. Clin Microbiol Infect; 2020 Jul 01; 26(7):944.e1-944.e7. PubMed ID: 31811916 [Abstract] [Full Text] [Related]
10. Identification of polysaccharide capsules among extensively drug-resistant genitourinary Haemophilus parainfluenzae isolates. González-Díaz A, Tubau F, Pinto M, Sierra Y, Cubero M, Càmara J, Ayats J, Bajanca-Lavado P, Ardanuy C, Marti S. Sci Rep; 2019 Mar 14; 9(1):4481. PubMed ID: 30872664 [Abstract] [Full Text] [Related]
12. Prevalence of Haemophilus influenzae with alteration of PBP 3 sequence over a 1-year period in a French hospital: focus on a clinical failure after ceftriaxone treatment. Thomas E, Guillouzouic A, Juvin ME, Chene AL, Caillon J, Bémer P, Corvec S. Diagn Microbiol Infect Dis; 2019 Feb 14; 93(2):89-91. PubMed ID: 30249513 [Abstract] [Full Text] [Related]
13. Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013. Skaare D, Anthonisen IL, Kahlmeter G, Matuschek E, Natås OB, Steinbakk M, Sundsfjord A, Kristiansen BE. Euro Surveill; 2014 Dec 11; 19(49):. PubMed ID: 25523969 [Abstract] [Full Text] [Related]
14. Fluoroquinolone, Macrolide, and Ketolide Resistance in Haemophilus parainfluenzae from South Africa. Abotsi RE, Govinden U, Moodley K, Essack S. Microb Drug Resist; 2017 Sep 11; 23(6):667-673. PubMed ID: 28103180 [Abstract] [Full Text] [Related]
15. Molecular characterization of macrolide resistance in Haemophilus influenzae and Haemophilus parainfluenzae strains (2018-21). Cadenas-Jiménez I, Saiz-Escobedo L, Carrera-Salinas A, Camprubí-Márquez X, Calvo-Silveria S, Camps-Massa P, Berbel D, Tubau F, Santos S, Domínguez MA, González-Díaz A, Ardanuy C, Martí S. J Antimicrob Chemother; 2024 Sep 03; 79(9):2194-2203. PubMed ID: 38946313 [Abstract] [Full Text] [Related]
16. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy. Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio G, Nicoletti G, Speciale AM, Schito GC. Int J Antimicrob Agents; 2005 Jul 03; 26(1):8-12. PubMed ID: 15967638 [Abstract] [Full Text] [Related]
17. Increasing resistance to fluoroquinolones among Haemophilus species in Southern Taiwan. Chang CM, Tang HJ, Wang LR, Shih HI, Huang CC, Lee NY, Lee CC, Ko WC. J Microbiol Immunol Infect; 2017 Apr 03; 50(2):258-260. PubMed ID: 27289531 [No Abstract] [Full Text] [Related]
18. [Septic osteoarthritis due to Haemophilus parainfluenzae]. Oehler E, Valour F. Med Mal Infect; 2014 Jan 03; 44(1):45-6. PubMed ID: 24387884 [No Abstract] [Full Text] [Related]
19. Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer. Kosikowska U, Biernasiuk A, Rybojad P, Łoś R, Malm A. BMC Microbiol; 2016 Apr 06; 16():62. PubMed ID: 27052615 [Abstract] [Full Text] [Related]
20. Genome-wide analysis of urogenital and respiratory multidrug-resistant Haemophilus parainfluenzae. Sierra Y, González-Díaz A, Carrera-Salinas A, Berbel D, Vázquez-Sánchez DA, Tubau F, Cubero M, Garmendia J, Càmara J, Ayats J, Ardanuy C, Marti S. J Antimicrob Chemother; 2021 Jun 18; 76(7):1741-1751. PubMed ID: 33792695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]